Robert Califf, Food and Drug Administration - Stanford Medicine Big Data | Precision Health 2016

TL;DR

The FDA discusses the impact of big data on regulatory processes and the opportunities and challenges it presents.

Transcript

thanks so much for that introduction it's always great to come back and see Dr Harrington we spent many years together in the trenches at uh Duke taking care of patients and now we're off into other Pursuits it's great to see uh his success I'm going to talk today about um big data and the FDA and let me just preface my remarks by saying I'm acutel... Read More

Key Insights

• 😃 The FDA is actively working on utilizing big data in various areas, including food safety, precision medicine, and evidence-based practice.
• 😷 The integration of electronic health records, claims data, and quality registries is crucial for developing a national medical evidence generation system.
• 🥺 The FDA believes that combining real-world data with randomized trials can lead to more informative and efficient clinical trials.

Questions & Answers

Q: How is the FDA using big data in the field of food safety?

The FDA is using whole genome sequencing and metagenomics to detect contaminants in food, identify sources of contamination, and track bacterial outbreaks. This data allows for proactive intervention and prevention of foodborne illnesses.

Q: How is the FDA incorporating big data in precision medicine initiatives?

The FDA is working on developing a national medical evidence generation system that integrates clinical care and research data. By utilizing electronic health records, claims data, and quality registries, the FDA aims to create a comprehensive source of information for evaluating medical products and informing clinical practice.

Q: What challenges does the FDA face in utilizing big data for evidence-based practice?

The FDA recognizes the need for high-quality data to support evidence-based practice. However, collecting long-term outcome data for maintaining health and preventing chronic diseases can be challenging. Balancing patient safety and innovation is a constant challenge for the FDA.

Q: How does the FDA view the increasing number of drug approvals in recent years?

The FDA evaluates drugs based on whether the benefits outweigh the risks, utilizing evidence that meets the standards of competent experts. The FDA believes that the revolution in biotechnology, targeted therapies, and big data will lead to a flood of effective treatments in the future.

Summary & Key Takeaways

• The FDA works in an ecosystem that promotes interaction between product developers, the FDA, and patients, creating opportunities for everyone involved.

• The FDA is utilizing big data in various aspects, including food safety, precision medicine, and evidence-based practice.

• Whole genome sequencing, microbiome analysis, and data sharing platforms like Precision FDA are helping improve regulatory processes and accelerate innovations.